KRT18 and breast carcinoma: Given that TGF-β1 can also promote the proliferation of epithelial breast cancer cells, TGF-β1 may enhance non-EMT CSC proliferation, leading to increased levels of E-cadherin and CK-18 in our experimental conditions.